What is Cleerly?
Cleerly is creating a new standard of care for heart disease through value-based, AI-driven precision diagnostic solutions with the goal of helping prevent heart attacks. Our technology goes beyond traditional measures of heart disease by enabling comprehensive quantification and characterization of atherosclerosis, or plaque buildup, in the heart's arteries. Cleerly’s solutions are supported by research gathered over more than 15 years in multi-center clinical trials.
CLEERLY'S TECHNOLOGYHow we work.
We are a remote first company with employees throughout the United States and in Portugal. Our teams connect over Slack, Zoom, and use Google Suite to collaborate daily. We encourage off-sites and have spaces in Denver, NYC, and Lisbon. We prioritize learning and growth as we face new challenges and responsibilities. Everyone on our team contributes to our success and receives equity in Cleerly.
MEET OUR LEADERSTaking care of our employees.
We have crafted generous benefits that include medical, dental, & vision with a variety of plans to choose from. In addition, we have an EAP program, a self-managed PTO policy, company holidays (including the week between Christmas Eve & New Years Day), 401K with company match, and a parental leave plan. We also give employees monthly stipends for WiFi/internet access and wellness, yearly stipends for learning & development and home office support. We are PEOPLE FIRST.
OPEN JOBS AT CLEERLY公司相册
员工视角
-
A New Standard of Precision Heart Care for 2023 and Beyond
A New Standard of Precision Heart Care for 2023 and Beyond
作者: James Min, MD
You’ve heard me say before that waste and inefficiency have plagued the cardiovascular care landscape. Current diagnosis methods miss 70% of all…
-
A Precise Approach to the Business of Healthcare
A Precise Approach to the Business of Healthcare
作者: James Min, MD
The business of healthcare is changing. With the transition to value-based care, a competitive market for patient acquisition and retention, and the…
-
Cleerly Closes Series C Funding Round with $192 Million
Cleerly Closes Series C Funding Round with $192 Million
作者: James Min, MD
Over the past year, we’ve been very busy at Cleerly, continuing to grow and remaining laser focused on achieving our mission to transition…